Home » Newsletters » BioWorld Science

BioWorld Science

May 6, 2015

View Archived Issues

Ebola vaccine based on the 2014 Zaire Guinea epidemic strain: Phase I clinical data

First preclinical data on Boehringer Ingelheim's novel MEK/Aurora kinase inhibitor

Pfizer reflects on achievements of first quarter 2015

EMA grants orphan drug designation to EspeRare's rimeporide for DMD

Braeburn acquires two new schizophrenia therapies

Preclinical findings with ADC BAY-1187982 lead to clinical study

Preliminary phase III results of Civacir to prevent HCV reinfection in liver transplant patients

Theraclone Sciences to screen antibodies from survivors of Ebola virus infection

Singulex and Dutch Technology Foundation launch Biomarker Development Center

Anti-CD73 MAb enhances antitumor activity of anti-PD-1 treatment

Sichuan Haisco Pharmaceutical discloses FXa inhibitors

Acetylon Pharmaceuticals patents HDAC inhibitors

Boehringer Ingelheim reports development of GlyT-1 inhibitors

Merck & Co. describes new Fc-containing polypeptides

Lilly presents novel NAMPT inhibitors

CytoDyn submits full phase III protocol to FDA for PRO-140 in HIV

Cypher Genomics and University of Pennsylvania to research genetic factors in PSP

Retrophin's RE-024 receives U.S. orphan drug designation for PKAN

Tenapanor fails to significantly reduce albuminuria in patients with CKD and type 2 diabetes

NCI launches phase III trial testing strategies for prevention of anal cancer

Primary endpoint met in phase IIb study of clazakizumab for rheumatoid arthritis

Teva reiterates proposal to acquire Mylan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...